Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Neosaxitoxin (NeoSTX) Alone and in Combination With Bupivacaine as Prolonged Duration Local Anesthetics: A Phase I Investigator-initiated Dose Escalation Study

NCT01786655 is registered in ClinicalTrials.gov with Charles Berde as lead sponsor.

NCT NCT01786655
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01786655 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Neosaxitoxin (NeoSTX) Alone and in Combination With Bupivacaine as Prolonged Duration Local Anesthetics: A Phase I Investigator-initiated Dose Escalation Study
Lead sponsor
Charles Berde
Phase
Phase 1
Overall status
Completed
Start date
May 31, 2013
Completion date
April 30, 2014
Enrollment
105 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

safety of neosaxitoxin in healthy volunteers